0      0

Global Expedited Programs for C&GTs

Jun 29, 2022 11:46am ‐ Jun 29, 2022 12:08pm

Credits: None available.


Gene, cellular and tissue-based therapies hold tremendous promise for addressing some of the most problematic diseases, including those without treatment options and rare genetic conditions. Developers of these therapies should work with regulators beginning at the earliest stages of development. The interactions with regulators on how to design the development program allows for a facilitation of the approval process and ultimately bringing the treatment to the patients.



Credits: None available.

You must be logged in and own this session in order to post comments.